MedPath

Tagged News

FDA Recalls Nearly 76,000 Cases of Eye Care Products Due to Manufacturing Deviations

  • The FDA has issued a recall for approximately 76,000 cases of over-the-counter ophthalmic products following an audit that revealed significant manufacturing deviations at BRS Analytical Services.
  • Five different eye care products are affected, including artificial tears and lubricant eye drops, distributed nationwide between May 2023 and April 2025, with expiration dates ranging through March 2027.
  • The recall stems from concerns about "lack of assurance of sterility," which could potentially compromise product safety, though the specific health hazards remain unknown.

FDA Recalls Six Acne Products After Testing Reveals Benzene Contamination Above Safety Limits

  • The FDA announced voluntary recalls of six popular acne products containing benzoyl peroxide after testing revealed elevated benzene levels above the conditional limit of two parts per million.
  • Independent testing by Valisure laboratory found that benzoyl peroxide breaks down into the carcinogen benzene over time, with some products containing levels as high as 35 ppm.
  • Of 95 acne products tested by the FDA, more than 90 percent had undetectable or extremely low benzene levels, but six products required recall due to elevated contamination.
  • Researchers emphasize that benzene exposure from multiple sources creates cumulative cancer risk, particularly concerning for products applied directly to skin.
© Copyright 2025. All Rights Reserved by MedPath